ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Santen Pharmaceutical Co., Ltd. ?
1
Poor Management Efficiency with a low ROE of 6.50%
- The company has been able to generate a Return on Equity (avg) of 6.50% signifying low profitability per unit of shareholders funds
2
Weak Long Term Fundamental Strength with a 1.43% CAGR growth in Operating Profits over the last 5 years
- The company has been able to generate a Return on Equity (avg) of 6.50% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Operating profit has grown by an annual rate 1.43% of over the last 5 years
4
Flat results in Jun 26
- OPERATING CASH FLOW(Y) Lowest at JPY 41,038 MM
- INVENTORY TURNOVER RATIO(HY) Lowest at 2.06 times
- INTEREST(Q) At JPY 738 MM has Grown at 44.14%
5
With ROE of 10.76%, it has a fair valuation with a 2.18 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 16.10%, its profits have risen by 11% ; the PEG ratio of the company is 1.6
- At the current price, the company has a high dividend yield of 0
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Santen Pharmaceutical Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
No Data Found
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
3.63%
EBIT Growth (5y)
1.43%
EBIT to Interest (avg)
20.31
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.22
Sales to Capital Employed (avg)
0.92
Tax Ratio
20.83%
Dividend Payout Ratio
33.32%
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
17.47%
ROE (avg)
6.50%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
2.18
EV to EBIT
14.37
EV to EBITDA
9.98
EV to Capital Employed
2.30
EV to Sales
2.06
PEG Ratio
1.61
Dividend Yield
NA
ROCE (Latest)
16.00%
ROE (Latest)
10.76%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
ROCE(HY)
Highest at 13.3%
RAW MATERIAL COST(Y)
Fallen by -7.69% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 4.45 times
-8What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at JPY 41,038 MM
INVENTORY TURNOVER RATIO(HY)
Lowest at 2.06 times
INTEREST(Q)
At JPY 738 MM has Grown at 44.14%
Here's what is working for Santen Pharmaceutical Co., Ltd.
Debtors Turnover Ratio
Highest at 4.45 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -7.69% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at JPY 4,718 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (JPY MM)
Here's what is not working for Santen Pharmaceutical Co., Ltd.
Operating Cash Flow
Lowest at JPY 41,038 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (JPY MM)
Interest
At JPY 738 MM has Grown at 44.14%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (JPY MM)
Inventory Turnover Ratio
Lowest at 2.06 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
